| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2872636 | 80 | M | IL | 11/13/2025 |
COVID19 COVID19 COVID19 |
MODERNA MODERNA MODERNA |
|
Blood test, Chills, Computerised tomogram, Culture, Feeling abnormal; Feeling co...
Blood test, Chills, Computerised tomogram, Culture, Feeling abnormal; Feeling cold, Malaise, Nausea, Pyrexia, Respiration abnormal; Tremor, Urine analysis
More
|
tremors; feeling of being cold to the bone; He felt unsteady and thought he had a fever; respiration...
tremors; feeling of being cold to the bone; He felt unsteady and thought he had a fever; respirations were rapid and labored; chills; nausea; unsteady and thought he had a fever; he felt a bit unwell earlier in the day; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (tremors), FEELING COLD (feeling of being cold to the bone), FEELING ABNORMAL (He felt unsteady and thought he had a fever), RESPIRATION ABNORMAL (respirations were rapid and labored) and MALAISE (he felt a bit unwell earlier in the day) in an 80-year-old male patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. The suspect product included Pre-filled Syringe injection for COVID-19 prophylaxis. The patient's past medical history included Unspecified septicemia (septicemia). Previously administered products included for Product used for unknown indication: Pfizer (dose 2), Pfizer (dose 1), Pfizer (dose 4) and Pfizer (dose 3). Past adverse reactions to the above products included No adverse effect with Pfizer, Pfizer, Pfizer and Pfizer. On 13-Oct-2025 at 10:30 AM, the patient received fifth dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient started Pre-filled Syringe (unknown route) at an unspecified dose. On 13-Oct-2025, the patient experienced MALAISE (he felt a bit unwell earlier in the day). On 13-Oct-2025 at 4:00 PM, after starting mRNA-1273.251 (Spikevax LP.8.1 PFS), the patient experienced TREMOR (tremors), FEELING COLD (feeling of being cold to the bone), FEELING ABNORMAL (He felt unsteady and thought he had a fever), RESPIRATION ABNORMAL (respirations were rapid and labored), CHILLS (chills), NAUSEA (nausea) and PYREXIA (unsteady and thought he had a fever). At the time of the report, TREMOR (tremors), FEELING COLD (feeling of being cold to the bone), FEELING ABNORMAL (He felt unsteady and thought he had a fever), RESPIRATION ABNORMAL (respirations were rapid and labored), MALAISE (he felt a bit unwell earlier in the day), CHILLS (chills), NAUSEA (nausea) and PYREXIA (unsteady and thought he had a fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2025, Blood test: Negative. In October 2025, Computerised tomogram: Negative. In October 2025, Culture: Negative. In October 2025, Urine analysis: Negative. No concomitant medication was reported. On 13-Oct-2025, the patient experienced a sudden onset of chills, tremors, and a feeling of being cold to the bone in the afternoon. He felt unsteady and thought he had a fever. He also had some nausea but no vomiting. His respirations were rapid and labored. The patient received the shot around 10:30 AM, and these symptoms began around 4:00 in the afternoon. Initially, he felt a bit unwell earlier in the day, but the significant symptoms started at 4:00 PM. His condition did not improve overnight, leading him to visit the ER, where he spent 7.5 hours. The medical team was concerned about sepsis due to his history of septicemia, but all tests, including blood work, cultures, urinalysis, and a CT scan, were negative. This led to the consideration that the COVID shot might be the cause, as this was his first Moderna vaccine after four Pfizer doses. The patient was not specifically informed about receiving Moderna, and since previous COVID shots were uneventful, patient did not inquire further. After several hours and test results, it was concluded that the vaccine was the likely cause, as no other factors changed that day. He did not have sepsis on 13-Oct-2025, although there was concern due to his history in Nov-2024 and Dec-2024. Following a battery of tests, sepsis was ruled out. A week later, an infectious disease doctor confirmed it was not an infection. It was unknown if the patient experienced any additional symptoms/events. He received treatment, including IVs, and began to feel better. Most recent FOLLOW-UP information incorporated above includes: On 07-Nov-2025: Live follow-up received: Reporter email id corrected, ROA updated, and reference ids added.
More
|
||||||
| 2872637 | 65 | TX | 11/13/2025 |
COVID19 FLUX |
MODERNA UNKNOWN MANUFACTURER |
|
Dyspepsia; Dyspepsia
Dyspepsia; Dyspepsia
|
digestive discomfort, such as stomach churning and gurgling noises; This spontaneous case was report...
digestive discomfort, such as stomach churning and gurgling noises; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (digestive discomfort, such as stomach churning and gurgling noises) in a 65-year-old patient of an unknown gender who received mRNA-1283 (MNEXSPIKE PFS) for COVID-19 prophylaxis. The suspect product included Pre-filled Syringe injection for COVID-19 prophylaxis. The non-company product included Influenza vaccine for an unknown indication. On an unknown date, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) 1 dosage form, Pre-filled Syringe (unknown route) at an unspecified dose and dose of Influenza vaccine (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPEPSIA (digestive discomfort, such as stomach churning and gurgling noises). At the time of the report, DYSPEPSIA (digestive discomfort, such as stomach churning and gurgling noises) had not resolved. Relevant Medical History (vaccines within the past 4 weeks, medical conditions) were reported as unknown. No concomitant medication was reported. Patient was experiencing digestive discomfort, such as stomach churning and gurgling noises, and was seeking advice on how to restore normal gut function. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported.
More
|
|||||||
| 2872638 | 78 | F | MA | 11/13/2025 |
COVID19 |
MODERNA |
|
Vaccination site reaction
Vaccination site reaction
|
reaction on arm below injection site/COVID arm; This spontaneous case was reported by a consumer and...
reaction on arm below injection site/COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (reaction on arm below injection site/COVID arm) in a 78-year-old female patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. The suspect product included Pre-filled Syringe injection for COVID-19 prophylaxis. No Medical History information was reported. On 05-Nov-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient started Pre-filled Syringe (unknown route) at an unspecified dose. In 2025, the patient experienced VACCINATION SITE REACTION (reaction on arm below injection site/COVID arm). At the time of the report, VACCINATION SITE REACTION (reaction on arm below injection site/COVID arm) was resolving. No concomitant medication was reported. Patient had Covid-19 shot on 05-Nov-2025, first time had reaction on arm below injection site. It fits all description of Covid arm. On the day of reporting, the arm was feeling better but still visible, injection had small faded black and blue. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported.
More
|
||||||
| 2872639 | CA | 11/13/2025 |
PNC20 |
PFIZER\WYETH |
LN4930 |
Cellulitis, Erythema, Swelling
Cellulitis, Erythema, Swelling
|
cellulitis; extreme redness; swelling; This is a spontaneous report received from an Other HCP. A p...
cellulitis; extreme redness; swelling; This is a spontaneous report received from an Other HCP. A patient (age and gender not provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Lot number: LN4930) for immunisation, Device Lot Number: LN4930. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CELLULITIS (medically significant), outcome "unknown"; ERYTHEMA (medically significant), outcome "unknown", described as "extreme redness"; SWELLING (medically significant), outcome "unknown". The events "cellulitis", "extreme redness" and "swelling" required emergency room visit. Clinical course: It was reported that they have a lot number that gave some patients what the doctor was considering abnormal reactions. Reporter stated they have another 16 doses of the same lot they just found that was affected. Stated that about 7 patients were involved with the previous report. Caller didn't have patient details to provide. Clarified abnormal reactions - stated the email she received states cellulitis, extreme redness, and swelling with one patient that went to the ER. States she not reporting anything new, just updating they have 16 doses of the same lot number that they found and quarantined. Confirms not administered to patients. She was looking to replace the 16 doses. The product sample was available to be returned. Packaging was sealed and intact. Causality for "cellulitis", "extreme redness" and "swelling" was determined associated to device constituent of pneumococcal 20-val conj vac (dipht CRM197 protein) (malfunction).; Sender's Comments: As there is limited information in the case provided, the causal association between the events cellulitis, erythema, and swelling; and the suspect drug PNEUMOCOCCAL 20-VAL CONJ VAC (DIPHT CRM197 PROTEIN) cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit-risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, ethics committees and investigators, as appropriate.
More
|
||||||||
| 2872640 | M | TN | 11/13/2025 |
COVID19 |
PFIZER\BIONTECH |
|
COVID-19, Drug ineffective, Influenza virus test, SARS-CoV-2 test
COVID-19, Drug ineffective, Influenza virus test, SARS-CoV-2 test
|
I tested positive this morning, today/ sick for about four- about five weeks or more and they finall...
I tested positive this morning, today/ sick for about four- about five weeks or more and they finally determined that I had COVID; I tested positive this morning, today/ sick for about four- about five weeks or more and they finally determined that I had COVID; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 72-year-old male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), in Sep2025 as dose 1, single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history included: "Cholesterol" (unspecified if ongoing); "blood pressure" (unspecified if ongoing). Concomitant medication(s) included: INFLUENZA taken for immunisation as dose number unknown, single; ATORVASTATIN taken for blood cholesterol abnormal; IRBESARTAN taken for blood pressure abnormal. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 4, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 5, SINGLE), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2025, outcome "unknown" and all described as "I tested positive this morning, today/ sick for about four- about five weeks or more and they finally determined that I had COVID". The patient underwent the following laboratory tests and procedures: Influenza virus test: (06Nov2025) Negative; SARS-CoV-2 test: (06Nov2025) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient reported that they have COVID after receiving vaccinations (Later vaccine name clarified as Pfizer COVID-19 Vaccine). Patient is prescribed the Paxlovid medication (Treatment). The patient stated he had a Pfizer Vaccine, and they said it was the most up to date one that he had it like the end of Sep2025. They said it was an up-to-date version. Consumer further stated, "Well, I had the vaccination right at the end of Sep and I got diagnosed with COVID today but I have been sick for probably four or five weeks or more. I am not saying that vaccine had anything to do with it, that's the reason I got the vaccine so I would not catch COVID. I do not know, I am not saying the vaccine caused it. It's the coincidence, I guess." When probed if consumer want to proceed with report or not, consumer stated, "Well, I am not blaming Pfizer. I have taken every COVID Shot, I have had ever since they came out with them and I have been five Pfizer already (Pfizer COVID-19 Vaccine). I have used every time because I have had never had a problem with them. I am happy with Pfizer. I am not trying to say Pfizer caused me to get sick." Date of vaccination: Consumer stated, "I am guessing right at the end of September and I do not know the exact date I got the vaccine. Somewhere around the 01Oct, I got end of Sep2025." Anatomical location, Consumer stated, "It might have been Sep. It's right at the end of Sep, I think. I am not sure because I got a Flu Shot one arm and I probably got it in the left arm but I do not know for sure. I did not get the shots the same day, I got them about a week apart. I got the COVID shot and about a week later, I got the Flu shot. So, I do not, probably my left arm but I can sure to it." Lab test: Consumer stated, "It has been longer than two weeks, I had this morning, they did a flu test and a covid test and flu test came back negative and the covid test swab came back positive. I have been sick probably five weeks, but this is getting worse." When clarified if tested positive after recent covid vaccine: Consumer stated, "This morning they tested me and said it was positive for covid." Patient did not receive any vaccines on the same date as Pfizer covid vaccine. If previously took Pfizer covid vaccine: Consumer stated, "I had every one, that they have come out with, I think I am up to date on my booster shot, this is first time I had covid." Treatment for covid: Consumer stated, "No, I just now felt I had it, I have not had a chance to go pick it up yet, when we hang up, I am going to head to drug store and get my medicine, 'while I can get started on it'." When clarified if prescribed with Paxlovid as a treatment: Consumer stated, "Yes."
More
|
|||||||
| 2872642 | 79 | M | OH | 11/13/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Heart rate, Heart rate increased, Hyperhidrosis, Tremor, Vomiting
Heart rate, Heart rate increased, Hyperhidrosis, Tremor, Vomiting
|
experiencing shaking after bath; sweating; vomiting; heart beats very quickly; This is a spontaneous...
experiencing shaking after bath; sweating; vomiting; heart beats very quickly; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID: . A 79-year-old male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 04Nov2025 as dose 1, single (Batch/Lot number: unknown) at the age of 79 years for covid-19 immunisation. The patient's relevant medical history included: "Covid", start date: 2020 (unspecified if ongoing), notes: in 2020, he got COVID and went to hospital.; "Chronic Lymphocytic Leukemia" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Bnt162b2, start date: 2020, for COVID-19 immunization, reaction(s): "shaking", notes: in 2020, he got COVID and went to hospital. He spent 11 days in the ICU. Then he took the COVID vaccine and experienced shaking & sweating on a 12 hour period; Bnt162b2, start date: 2020, for COVID-19 immunization, reaction(s): "sweating", notes: in 2020, he got COVID and went to hospital. He spent 11 days in the ICU. Then he took the COVID vaccine and experienced shaking & sweating on a 12 hour period; Bnt162b2, start date: 2023, for COVID-19 immunization, reaction(s): "shaking", notes: after 3 years he was administered with COVID vaccine and had the same reaction; Bnt162b2, start date: 2023, for COVID-19 immunization, reaction(s): "sweating", notes: after 3 years he was administered with COVID vaccine and had the same reaction. The following information was reported: TREMOR (hospitalization, life threatening) with onset Nov2025, outcome "recovered", described as "experiencing shaking after bath"; HEART RATE INCREASED (non-serious) with onset Nov2025, outcome "unknown", described as "heart beats very quickly"; HYPERHIDROSIS (non-serious) with onset Nov2025, outcome "recovered", described as "sweating"; VOMITING (non-serious) with onset Nov2025, outcome "unknown". The patient underwent the following laboratory tests and procedures: Heart rate: very quickly. Additional information: Caller elaborated that he was last administered with Comirnaty on 04Nov2025 and in 2020, he got COVID and went to hospital. He spent 11 days in the ICU. Then he took the COVID vaccine and experienced shaking & sweating on a 12 hour period, after 3 years he was administered with COVID vaccine and had the same reaction. When paraphrased the above concern, consumer stated, "I started, in 2020, I got COVID and spend 11 days in ICU. 21 comes along and I took the shot (Pfizer COVID-19 Vaccine) and that evening until the next morning, I had sweats and shaking and very uncomfortable. Next year comes around, I do the same thing, this year, I come around I do the same thing, except this time, I throw up and my heart was just pounding. My concern is like I said I spend 11 days in ICU, I am thinking, should I continue to take this shot? Because I am 79 years old." The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.
More
|
โ | โ | ||||
| 2872643 | 11/13/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Arteriosclerosis, Cerebrovascular accident, Type 2 diabetes mellitus
Arteriosclerosis, Cerebrovascular accident, Type 2 diabetes mellitus
|
CVA; uncontrolled type 2 DM; atherosclerotic CVD; This is a spontaneous report received from a Physi...
CVA; uncontrolled type 2 DM; atherosclerotic CVD; This is a spontaneous report received from a Physician. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: CEREBROVASCULAR ACCIDENT (death, hospitalization), outcome "fatal", described as "CVA"; TYPE 2 DIABETES MELLITUS (death, hospitalization), outcome "fatal", described as "uncontrolled type 2 DM"; ARTERIOSCLEROSIS (death, hospitalization), outcome "fatal", described as "atherosclerotic CVD". Therapeutic measures were taken as a result of cerebrovascular accident, type 2 diabetes mellitus, arteriosclerosis. The patient date of death was Feb2021. Reported cause of death: "CVA", "uncontrolled type 2 DM", "atherosclerotic CVD". It was not reported if an autopsy was performed. Clinical course: HCP is Nephrologist is a large private practice. One of his HD patients developed a CVA 5 weeks after Cormirnaty. He ascribes this to the vaccine and did not take into account uncontrolled type 2 DM and atherosclerotic CVD as potential confounding factors. Ae resulted in: Hospitalization, Patient died. Date of death: Feb2021. If autopsy performed: Unknown. If treatment AE: Yes. AE treatment: Details not known The information on the batch/lot number for [BNT162B2 OMICRON (LP.8.1)] will be requested and submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the events cerebrovascular accident, type 2 diabetes mellitus, and arteriosclerosis; and the suspect drug BNT162B2 OMICRON (LP.8.1) cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit-risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, ethics committees and investigators, as appropriate.; Reported Cause(s) of Death: CVA; uncontrolled type 2 DM; atherosclerotic CVD
More
|
โ | โ | |||||||
| 2872644 | M | OH | 11/13/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Discomfort, Hyperhidrosis, Tremor
Discomfort, Hyperhidrosis, Tremor
|
sweats; shaking; Very uncomfortable; This is a spontaneous report received from a Consumer or other ...
sweats; shaking; Very uncomfortable; This is a spontaneous report received from a Consumer or other non HCP, Program ID: . A 75-year-old male patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "COVID-19", start date: 2020 (unspecified if ongoing); "ICU", start date: 2020 (unspecified if ongoing), notes: 11 days in ICU. The patient's concomitant medications were not reported. The following information was reported: DISCOMFORT (non-serious) with onset 2021, outcome "recovered", described as "Very uncomfortable"; TREMOR (non-serious) with onset 2021, outcome "recovered", described as "shaking"; HYPERHIDROSIS (non-serious) with onset 2021, outcome "recovered", described as "sweats". Additional information: The patient experience about the Pfizer COVID-19 Vaccine. So, just want to add some more information that the patient experiences shaking and sweating after the Pfizer COVID-19 Vaccine and then, it takes 12 hours to get rid of what they experienced. When paraphrased the above concern, consumer stated, patient started, in 2020, he got COVID and spend 11 days in ICU. 21 comes along and he took the shot (Pfizer COVID-19 Vaccine) and that evening until the next morning, he had sweats and shaking and very uncomfortable. Next year comes around, he did the same thing, this year, he comes around he do the same thing, except this time, he throws up and his heart was just pounding. His concern was like he said he spend 11 days in ICU, he was thinking, should he continue to take this shot. Because he was 79 years old. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.
More
|
|||||||
| 2872645 | 11/13/2025 |
COVID19 COVID19 |
MODERNA PFIZER\BIONTECH |
|
COVID-19, Drug ineffective; COVID-19, Drug ineffective
COVID-19, Drug ineffective; COVID-19, Drug ineffective
|
Covid-19; Covid-19; This is a spontaneous report received from a Consumer or other non HCP. Other Ca...
Covid-19; Covid-19; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): MOD-2025-790706 (Moderna). A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (SPIKEVAX), as dose 1, single intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. It was reported that the patient never had COVID in the last five years. Vaccination history included: Covid-19 vaccine (MANUFACTURER UNKNOWN (received every single vaccine that was ever been offered. Some were moderna, some were Pfizer)), for COVID-19 immunisation. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 01Sep2025, outcome "recovering" and all described as "Covid-19". The event "covid-19" required physician office visit. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: On 01Sep2025 the patient got the COVID at the beach. The patient was a little sick. The symptoms were not like a typical cold sore throat and then the patient had a tight chest. The patient did not experience sneezing or coughing, but the patient had a tight chest. The patient received treatment of Paxlovid in Sep2025 for COVID-19, and the patient symptoms get better after 7 days. The patient believed this COVID-19 infection must be very mutated interaction. Because the patient received every single vaccine that was ever been offered. Like with example Some were moderna, some were Pfizer, and the patient traveled to seven countries and four continents, and never had COVID-before. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
More
|
|||||||||
| 2872646 | 11/13/2025 |
COVID19 |
PFIZER\BIONTECH |
|
COVID-19
COVID-19
|
I got my Covid vaccines, but still had a few hours with Covid anyway; This is a spontaneous report r...
I got my Covid vaccines, but still had a few hours with Covid anyway; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (non-serious), outcome "unknown", described as "I got my Covid vaccines, but still had a few hours with Covid anyway". No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
More
|
|||||||||
| 2872647 | 4 | F | 11/13/2025 |
FLU3 FLU3 |
SANOFI PASTEUR SANOFI PASTEUR |
|
Dysstasia, Gait disturbance, Injection site erythema, Injection site rash, Injec...
Dysstasia, Gait disturbance, Injection site erythema, Injection site rash, Injection site warmth; Motor dysfunction, Muscular weakness, Pain in extremity, Pruritus
More
|
motor skills and lower limb strength have decreased significantly; frequently tripping; unable to st...
motor skills and lower limb strength have decreased significantly; frequently tripping; unable to stand without sitting for a length of time; lower limb strength have decreased significantly; legs hurt; injection site was red; injection site was hot to the touch; injection site was red, hot to the touch, with a rash running up and down; extreme itchiness; Initial information received on 05-Nov-2025 regarding an unsolicited valid non-serious case received from a consumer/Non-Healthcare Professional. This case involves a 4 years old female patient who had motor skills and lower limb strength have decreased significantly, frequently tripping, unable to stand without sitting for a length of time, extreme itchiness, lower limb strength have decreased significantly, legs hurt, injection site was red, injection site was hot to the touch and injection site was red, hot to the touch, with a rash running up and down after receiving INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 23-Oct-2025, the patient received INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE Suspension for injection (strength, dose, batch and expiry date unknown) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation) . Information on batch number and expiry date corresponding to the one at time of event occurrence was requested. On 24-OCT-2025 the patient had injection site was red (vaccination site erythema), injection site was hot to the touch (vaccination site warmth), injection site was red, hot to the touch, with a rash running up and down (vaccination site rash) and extreme itchiness (pruritus) (latency 1 day). On an unknown date in Nov 2025 the patient had motor skills and lower limb strength have decreased significantly (psychomotor skills impaired), frequently tripping (fall),unable to stand without sitting for a length of time (dysstasia),lower limb strength have decreased significantly (asthenia)and legs hurt (pain in extremity) (latency2 weeks approximately). It was reported "they were looking to order blood tests to rule out GBS (Guillain Barre syndrome), myositis, SMA (Spinal muscular atrophy), Lyme, etc. My 2year old daughter received the same vaccine at the same time without incident" Action taken- not applicable. It was not reported if the patient received a corrective treatment for the events At time of reporting, the outcome was Recovered / Resolved on 25-Oct-2025 for the events vaccination site erythema,vaccination site warmth, vaccination site rash and pruritus, unknown for other events
More
|
|||||||
| 2872649 | 67 | F | PA | 11/13/2025 |
FLU3 |
SANOFI PASTEUR |
U8874BA |
Heart rate increased, Hypertension, Pharyngeal swelling, Uvulitis
Heart rate increased, Hypertension, Pharyngeal swelling, Uvulitis
|
diagnosed with uvulitis; back of their throat was swollen; had high blood pressure; high heart rate;...
diagnosed with uvulitis; back of their throat was swollen; had high blood pressure; high heart rate; Initial information received on 06-Nov-2025 regarding an unsolicited valid non-serious case (along with live follow -up attached with csd dated:06-Nov-2025) received from a Patient. This case involves a 67 years old female patient who had diagnosed with uvulitis, high blood pressure and high heart rate after receiving Influenza Usp Trival A-B High Dose Subvirion Vaccine [Fluzone Hd]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Nov-2025, the patient received 0.5 ml dose of suspect Influenza Usp Trival A-B High Dose Subvirion Vaccine, Suspension for injection in pre-filled syringe, lot U8874BA, expiry date: 30-Jun-2026, frequency: once, strength high dose, via intramuscular route in the left arm for Influenza [Influenza immunisation]. On 04-Nov-2025 the patient had diagnosed with uvulitis (uvulitis), had high blood pressure (hypertension), back of their throat was swollen (pharyngeal swelling) and high heart rate (heart rate increased) (latency: 2 days). Relevant laboratory test results included: Blood pressure measurement - On 04-Nov-2025: 157/84 UNK [157/84] Heart rate - On 04-Nov-2025: 122 beats/min Action taken was not applicable. Treatment: The patient was treated with Ketorolac tromethamine (Toradol) through the IV for Uvulitis and Pharyngeal swelling, Methylprednisolone sodium succinate (Solu medrol) for Uvulitis and Pharyngeal swelling and when they were discharged, given with Prednisone. It was not reported if the patient received a corrective treatment for the events (high blood pressure and high heart rate). At time of reporting, the outcome was Unknown for all the events.
More
|
||||||
| 2872650 | 10 | M | CA | 11/13/2025 |
COVID19 |
MODERNA |
3052583 |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
Patient 10 years old, was administered Moderna 12 years+ COVID-19 vaccination. Dose not appropriate ...
Patient 10 years old, was administered Moderna 12 years+ COVID-19 vaccination. Dose not appropriate for age
More
|
||||||
| 2872651 | 32 | F | MA | 11/13/2025 |
COVID19 |
NOVAVAX |
6315MF001C |
Chest pain, Echocardiogram abnormal, Electrocardiogram normal, Pericardial effus...
Chest pain, Echocardiogram abnormal, Electrocardiogram normal, Pericardial effusion, Pericarditis
More
|
Chest pain began with within one hour of vaccine administration and continued. Patient presented to ...
Chest pain began with within one hour of vaccine administration and continued. Patient presented to the emergency department the following day. Concern for pericarditis was confirmed with echocardiogram on 11/13 with trace pericardial effusion
More
|
โ | |||||
| 2872652 | 47 | F | NJ | 11/13/2025 |
FLU3 |
SANOFI PASTEUR |
U8881DA |
Injection site erythema, Injection site pruritus, Injection site swelling
Injection site erythema, Injection site pruritus, Injection site swelling
|
Patient complains of Redness, and swelling to the injection site on left arm. Area is itchy too.
Patient complains of Redness, and swelling to the injection site on left arm. Area is itchy too.
|
||||||
| 2872654 | 70 | F | NY | 11/13/2025 |
FLU3 |
SANOFI PASTEUR |
ut8794aa |
Dizziness
Dizziness
|
Pt complained of feeling dizzy a couple of hours after receiving the vaccine. She said she was goin...
Pt complained of feeling dizzy a couple of hours after receiving the vaccine. She said she was going to go home and rest.
More
|
||||||
| 2872655 | 62 | F | ID | 11/13/2025 |
FLU3 |
SEQIRUS, INC. |
AX4142A |
Bursitis, Joint range of motion decreased, Pain, Sleep disorder
Bursitis, Joint range of motion decreased, Pain, Sleep disorder
|
Pt states she had pain almost immediately after the flu vaccination that progressed over the next 3 ...
Pt states she had pain almost immediately after the flu vaccination that progressed over the next 3 days. Has decreased range of motion and pain that wakes her during the night. Provider determined pain from bursitis of the right shoulder and patient received an injection of 3cc of 1% lidocaine with 2cc of Celestone into the bursa guided by ultrasound on 11/3/25.
More
|
||||||
| 2872660 | 17 | M | WA | 11/13/2025 |
COVID19 FLU3 |
PFIZER\BIONTECH SANOFI PASTEUR |
NA0590 UT8861MA |
Dizziness; Dizziness
Dizziness; Dizziness
|
Per pt. mother, patient took blood pressure medication, Candesartan 15 mg, one hour prior to coming...
Per pt. mother, patient took blood pressure medication, Candesartan 15 mg, one hour prior to coming for vaccinations. At the time of vaccination, patient' s parents did not mention it to me. Patient is a new patient to us. he received two vaccines, Corminaty and Fluzone TRIV, went to the restroom, then stopped by the drop off window. Approximately, 7 minutes after the vaccination, the patient felt light headness sat on the ground slowly without hitting his head. Patient was counseled regarding the possible side effects associated with the vaccines. EMS called by pt's father and patient was released by EMT after 15 minutes.
More
|
||||||
| 2872662 | 70 | M | ID | 11/13/2025 |
FLU3 |
SANOFI PASTEUR |
UT8829AA |
Injection site erythema, Injection site swelling, Injection site warmth
Injection site erythema, Injection site swelling, Injection site warmth
|
Redness that is localized in a 3-inch diameter around injection site. It is warm to the touch compar...
Redness that is localized in a 3-inch diameter around injection site. It is warm to the touch comparatively and slightly raised. No complaint of pain.
More
|
||||||
| 2872669 | 40 | F | MN | 11/13/2025 |
FLU3 |
SANOFI PASTEUR |
UT8826JA |
Arthralgia, Discomfort, Pain
Arthralgia, Discomfort, Pain
|
Had radiating pain all the way medial to my shoulder blade. I have been taking Ibuprofen, using lid...
Had radiating pain all the way medial to my shoulder blade. I have been taking Ibuprofen, using lidocaine patches and different pain creams(Penetrex, Voltaren, Biofreeze). Overnight and today it became very much worse and can find no comfortable position.
More
|
||||||
| 2872670 | 84 | M | KS | 11/13/2025 |
COVID19 FLU3 RSV |
MODERNA SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS |
3052035 u8862ca cm9a5 |
Chills, Cough, Oropharyngeal pain, Productive cough; Chills, Cough, Oropharyngea...
Chills, Cough, Oropharyngeal pain, Productive cough; Chills, Cough, Oropharyngeal pain, Productive cough; Chills, Cough, Oropharyngeal pain, Productive cough
More
|
Pt recieved vaccines on Wed 11/5/26. By Thursday he was having chills. Saturday he started having a...
Pt recieved vaccines on Wed 11/5/26. By Thursday he was having chills. Saturday he started having a sore throat, coughing, phlegm. He started feeling better Monday 11/10/25
More
|
||||||
| 2872671 | 84 | M | FL | 11/13/2025 |
COVID19 |
NOVAVAX |
6315MF002C |
Chills, Fatigue, Laboratory test, Peripheral swelling, Pyrexia
Chills, Fatigue, Laboratory test, Peripheral swelling, Pyrexia
|
PATIENT EXPERIENCED FEVER (100.5F), CHILLS, FATIGUE AND SWELLING OF BOTH LEGS. HE TOOK TYLENOL FOR T...
PATIENT EXPERIENCED FEVER (100.5F), CHILLS, FATIGUE AND SWELLING OF BOTH LEGS. HE TOOK TYLENOL FOR THE FEVER. PATIENT NOTED HIS LEGS SWELLING ASOF THREE DAYS AGO (11/10/25) AND HAD TO SEE HIS PROVIDER. HE IS CURRENTLY BEING TREATED WITH FUROSEMIDE 20 MG DAILY AND PREDNISONE 20 MG DAILY FOR THE LEG SWELLING.
More
|
||||||
| 2872672 | 83 | M | FL | 11/13/2025 |
COVID19 FLU3 |
PFIZER\BIONTECH SANOFI PASTEUR |
NA4452 UT8781DA |
Death, Fatigue, General physical health deterioration, Lethargy, Malaise; Death,...
Death, Fatigue, General physical health deterioration, Lethargy, Malaise; Death, Fatigue, General physical health deterioration, Lethargy, Malaise
More
|
Patient's son came to pharmacy 11/12/25 to inform pharmacy that the patient passed away 10/26/2...
Patient's son came to pharmacy 11/12/25 to inform pharmacy that the patient passed away 10/26/25, 10 days post vaccines. He informed us that his father was in hospice for the past several months for cancer but was stable (though he remarked his father would have appeared unwell and should not have received vaccines though we had consent form where he did not indicate any cold, fever or acute illness) and a few days post vaccine he was feeling very fatigued and feel acutely ill/lethargic and went into care and passed that week later. Though his father had cancer his son feels that he should not have rapidly deteriorated in health so shortly after vaccines.
More
|
โ | |||||
| 2872674 | 10 | M | MD | 11/13/2025 |
COVID19 |
PFIZER\BIONTECH |
T5727 |
Wrong product administered
Wrong product administered
|
The patient received COMIRNATY 5-11Y vaccine instead of Varicella vaccine
The patient received COMIRNATY 5-11Y vaccine instead of Varicella vaccine
|
||||||
| 2872675 | 42 | M | IL | 11/13/2025 |
COVID19 FLU3 |
PFIZER\BIONTECH SEQIRUS, INC. |
|
Pain, Pain in extremity; Pain, Pain in extremity
Pain, Pain in extremity; Pain, Pain in extremity
|
Arm has felt similar to pain day after the vaccination. Dull pain around deltoid, below injection si...
Arm has felt similar to pain day after the vaccination. Dull pain around deltoid, below injection site. Pain increases with different routine arm movements.
More
|
||||||
| 2872676 | 16 | M | CO | 11/13/2025 |
COVID19 FLU3 HEPA HPV9 IPV MNQ TDAP |
MODERNA GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. SANOFI PASTEUR NOVARTIS VACCINES AND DIAGNOSTICS GLAXOSMITHKLINE BIOLOGICALS |
3052668 2NG23 MB599 Y018416 Y1A212M 9549B 4K7JP |
Hypotonia, Loss of consciousness; Hypotonia, Loss of consciousness; Hypotonia, L...
Hypotonia, Loss of consciousness; Hypotonia, Loss of consciousness; Hypotonia, Loss of consciousness; Hypotonia, Loss of consciousness; Hypotonia, Loss of consciousness; Hypotonia, Loss of consciousness; Hypotonia, Loss of consciousness
More
|
Patient to receive 10 vaccines due to need to catch up on vaccines and Flu and COVID. Nurse number 1...
Patient to receive 10 vaccines due to need to catch up on vaccines and Flu and COVID. Nurse number 1 was giving vaccines on patients right arm; Nurse #2 was giving vaccines on the left arm. When nurse #1 gave the 5th shot (HPV) on the right arm, patient slumped down. The nurses gently got patient to floor, elevated his legs, he felt better within seconds, patient stated "he dreamt for a few seconds, then woke up". Vital signs were monitored and he was kept on the floor with his feet elevated. He was given water and offered gummy fruit snacks which he took and fed himself. FOC was called, as he worked nearby. The school nurse and Nurse #2 explained the incident to the FOC. Also, advised him that the patient did not receive 2 vaccines (MMR & varicella). FOC declined further vaccine administration after incident.
More
|
||||||
| 2872677 | 32 | M | AK | 11/13/2025 |
COVID19 FLU3 |
PFIZER\BIONTECH SANOFI PASTEUR |
|
Fatigue, Pain, Pyrexia; Fatigue, Pain, Pyrexia
Fatigue, Pain, Pyrexia; Fatigue, Pain, Pyrexia
|
High fever, body aches and fatigue
High fever, body aches and fatigue
|
||||||
| 2872679 | 72 | F | PA | 11/13/2025 |
COVID19 |
PFIZER\BIONTECH |
NA0590 |
Injection site pruritus, Injection site swelling
Injection site pruritus, Injection site swelling
|
PT reported that approximately 4 hours after receiving the vaccine, the injection site was swollen a...
PT reported that approximately 4 hours after receiving the vaccine, the injection site was swollen and itchy. Pt stated that she applied alcohol, but that did not resolve the issue. Reminded pt that while pain and swelling at the injection site are not uncommon after an immunization, combined with the itching there is a concern for possible infection. Recommended that the pt contact her physician for further medical advice on this situation,.
More
|
||||||
| 2872680 | 54 | M | ID | 11/13/2025 |
FLU3 |
SEQIRUS, INC. |
408924 |
No adverse event, Wrong product administered
No adverse event, Wrong product administered
|
No adverse reaction reported by the patient at this time. Patient was given FLUAD instead of FLUCELV...
No adverse reaction reported by the patient at this time. Patient was given FLUAD instead of FLUCELVAX.
More
|
||||||
| 2872683 | 62 | F | WA | 11/13/2025 |
UNK |
UNKNOWN MANUFACTURER |
23E4B |
Injection site reaction, Pain, Pyrexia, Rash erythematous
Injection site reaction, Pain, Pyrexia, Rash erythematous
|
Pt reports fever and aches x2d after vaccine. Now have a red rash around injection site that spread ...
Pt reports fever and aches x2d after vaccine. Now have a red rash around injection site that spread down to-bicep; pt reports rash is getting better. no other adverse reactions reported.
More
|
||||||
| 2872684 | 53 | M | AL | 11/13/2025 |
FLU3 PNC20 |
SANOFI PASTEUR PFIZER\WYETH |
U8823DA LX4482 |
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
Patient requested pneumonia vaccine. Patient profile (only contains one year of history) reviewed f...
Patient requested pneumonia vaccine. Patient profile (only contains one year of history) reviewed for history of pneumonia vaccines in addition to state immunization registry neither of which reflected any history of patient ever receiving a pneumonia vaccine. Patient was given Prevnar 20 vaccine. We later received an email from pharmacy indicating that patient had already received a Prevnar 20 vaccine on 11/02/2023. Patient experienced no adverse effects and no treatment was required.
More
|
||||||
| 2872685 | 72 | F | IL | 11/13/2025 |
FLU3 |
SANOFI PASTEUR |
U8855AA |
Pruritus, Skin burning sensation
Pruritus, Skin burning sensation
|
Patient got a flu shot (Fluzone HD) on 10/29/25. Pt reports that later that night she got a burning ...
Patient got a flu shot (Fluzone HD) on 10/29/25. Pt reports that later that night she got a burning sensation on one side of her face. She says that feeling changed to an itching sensation and spread over her whole body. As of 11/12/25, she says she is still dealing with these symptoms. She has taken allergy medications and steroids but hasn't gotten rid of the itching yet. Patient states that she never developed a rash.
More
|
||||||
| 2872690 | 43 | M | 11/13/2025 |
COVID19 |
MODERNA |
|
No adverse event, Wrong product administered
No adverse event, Wrong product administered
|
Patient was inadvertently given Mnexspike at vaccination event instead of Spikevax despite no known ...
Patient was inadvertently given Mnexspike at vaccination event instead of Spikevax despite no known health conditions that increase risk for severe outcomes from COVID. No adverse reaction noted. Patient notified of administration error.
More
|
|||||||
| 2872691 | 41 | F | WA | 11/13/2025 |
COVID19 |
MODERNA |
|
No adverse event, Wrong product administered
No adverse event, Wrong product administered
|
Patient was inadvertently given Mnexspike at vaccination event instead of Spikevax despite no known ...
Patient was inadvertently given Mnexspike at vaccination event instead of Spikevax despite no known health conditions that increase risk for severe outcomes from COVID. No adverse reaction noted. Patient notified of administration error.
More
|
||||||
| 2872703 | 45 | F | NJ | 11/13/2025 |
FLU3 |
SANOFI PASTEUR |
U9923DA |
Pain, Pyrexia
Pain, Pyrexia
|
Aprox. 6:30pm, same day as vaccination, started with a low grade fever and body aches. Temperature w...
Aprox. 6:30pm, same day as vaccination, started with a low grade fever and body aches. Temperature went away by morning. Body aches lasted for 2 days.
More
|
||||||
| 2872704 | 81 | F | NY | 11/13/2025 |
FLU3 |
SEQIRUS, INC. |
407275 |
Arthralgia, Pain in extremity
Arthralgia, Pain in extremity
|
Severe pain in arm and shoulder. Patient went to doctor and needed to get steroid shot. Patient stat...
Severe pain in arm and shoulder. Patient went to doctor and needed to get steroid shot. Patient stated some relief after steroid shot.
More
|
||||||
| 2872173 | M | WI | 11/12/2025 |
VARZOS VARZOS VARZOS VARZOS VARZOS VARZOS VARZOS VARZOS |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
UNK UNK UNK UNK UNK UNK UNK UNK |
Areflexia, Diplopia, Eye movement disorder, Gag reflex test, HIV test negative; ...
Areflexia, Diplopia, Eye movement disorder, Gag reflex test, HIV test negative; Herpes zoster, Herpes zoster reactivation, Lymph node pain, Ophthalmic herpes zoster, Oropharyngeal pain; Rash, Rash vesicular, Skin discolouration, Slit-lamp tests normal, Streptococcus test negative; Tonsillar exudate, Tonsillar hypertrophy, VIth nerve paralysis, Vaccination failure, Visual acuity reduced; Areflexia, Diplopia, Eye movement disorder, Gag reflex test, HIV test negative; Herpes zoster, Herpes zoster reactivation, Lymph node pain, Ophthalmic herpes zoster, Oropharyngeal pain; Rash, Rash vesicular, Skin discolouration, Slit-lamp tests normal, Streptococcus test negative; Tonsillar exudate, Tonsillar hypertrophy, VIth nerve paralysis, Vaccination failure, Visual acuity reduced
More
|
right-sided scalp discoloration; vesicular rash; right-sided sore throat; tonsillar exudate; he had ...
right-sided scalp discoloration; vesicular rash; right-sided sore throat; tonsillar exudate; he had a decreased gag reflex; tenderness to the preauricular and cervical chain lymph nodes; right tonsil was enlarged without exudate; dermatomal rash; suspected vaccination failure; Herpes zoster ophthalmicus / VZV reactivation; herpes zoster infection/Varicella zoster virus reactivation; cranial nerve VI palsy; acute double vision / diplopia; This serious case was reported in a literature article and described the occurrence of vaccination failure in a 82-year-old male patient who received Herpes zoster (Zoster vaccine) for prophylaxis. Literature Reference: Co-suspect products included Herpes zoster (Zoster vaccine) for prophylaxis. The patient's past medical history included shingles (Years prior to his presentation). Previously administered products included zoster vaccine with an associated reaction of no adverse event (live zoster vaccine). Concurrent medical conditions included keratoconus, nuclear cataract (ophthalmology clinic), thyroid gland cancer, thyroidectomy, prostate cancer, radical retropubic prostatectomy, radioactive iodine therapy, hyperlipidemia, hypertension, mycobacterium avium complex infection, bronchiectasis and asthma. Additional patient notes included He had no vision changes, ear pain, ear drainage, headache, anosmia, or nose lesions. Concomitant products included sulfamethoxazole;trimethoprim. In 2019, the patient received Zoster vaccine. In 2018, the patient received Zoster vaccine. On an unknown date, an unknown time after receiving Zoster vaccine and Zoster vaccine, the patient experienced vaccination failure (Verbatim: suspected vaccination failure) (serious criteria GSK medically significant), ophthalmic herpes zoster (Verbatim: Herpes zoster ophthalmicus / VZV reactivation) (serious criteria GSK medically significant), herpes zoster (Verbatim: herpes zoster infection/Varicella zoster virus reactivation), vith nerve palsy (Verbatim: cranial nerve VI palsy) (serious criteria GSK medically significant), double vision (Verbatim: acute double vision / diplopia), skin discoloration (Verbatim: right-sided scalp discoloration), vesicular rash (Verbatim: vesicular rash), sore throat (Verbatim: right-sided sore throat), tonsillar exudate (Verbatim: tonsillar exudate), gagging (Verbatim: he had a decreased gag reflex), lymph node tenderness (Verbatim: tenderness to the preauricular and cervical chain lymph nodes), swollen tonsils (Verbatim: right tonsil was enlarged without exudate) and rash (Verbatim: dermatomal rash). The patient was treated with valaciclovir (Valacyclovir). The outcome of the vaccination failure, ophthalmic herpes zoster, herpes zoster, vith nerve palsy, skin discoloration, vesicular rash, sore throat, tonsillar exudate, gagging, lymph node tenderness and swollen tonsils were not reported and the outcome of the double vision was resolved (duration 3 days) and the outcome of the rash was resolving. The reporter considered the vaccination failure, ophthalmic herpes zoster, herpes zoster, vith nerve palsy, double vision, skin discoloration, vesicular rash, sore throat, tonsillar exudate, gagging, lymph node tenderness, swollen tonsils and rash to be related to Zoster vaccine and Zoster vaccine. The company considered the vaccination failure, herpes zoster, double vision, skin discoloration, vesicular rash, sore throat, tonsillar exudate, gagging, lymph node tenderness, swollen tonsils and rash to be related to Zoster vaccine and Zoster vaccine. The company considered the ophthalmic herpes zoster and vith nerve palsy to be unrelated to Zoster vaccine and Zoster vaccine. Additional Information: GSK Receipt Date: 25-Mar-2024 The author presented an 82-year-old man with a past ocular history of keratoconus and bilateral nuclear sclerotic cataracts presented to the ophthalmology clinic with a 3-day history of acute double vision His past medical history was remarkable for thyroid cancer status post thyroidectomy and radioactive iodine, prostate cancer status post radical retropubic prostatectomy, hyperlipidemia, hypertension, severe asthma, and bronchiectasis, as well as history of pulmonary mycobacterium avium-intracellulare superimposed on pulmonary norcardiosis, for which he was on chronic trimethoprim/sulfamethoxazole and followed closely by infectious disease. Notably, he was HIV negative and with no other underlying immunologic or immunosuppressive conditions. Years prior to his presentation, he had shingles of his left flank. He received the live zoster vaccine in 2011 and the recombinant zoster vaccine in 2018 and 2019. Fourteen days prior to the onset of diplopia, he was seen by infectious disease for right-sided scalp discoloration and vesicular rash that began approximately 1 week after he had a right-sided sore throat with white, tonsillar exudate. On exam, he had a decreased gag reflex, tenderness to the preauricular and cervical chain lymph nodes, and the right tonsil was enlarged without exudate. A rapid strep test was negative. He had no vision changes, ear pain, ear drainage, headache, anosmia, or nose lesions. He was diagnosed with Herpes zoster ophthalmicus (HZO) and treated with a 10-day course of oral valacyclovir. The infectious disease specialist believed the sore throat was related to zoster polyneuropathy of cranial nerve IX and X. When presenting to the ophthalmology clinic, the patient described his double vision as constant, binocular, and horizontal. He stated that it became worse when looking right, and he experienced notable improvement when looking left. His visual acuity was 20/50 in each eye, and both pupils were equal and reactive without an afferent pupillary defect. Confrontation visual fields were full in both eyes. Extraocular movements were notable for limited abduction of the right eye. Extraocular movements were normal and full in the left eye. Slit lamp exam was negative for eyelid vesicular lesions, conjunctivitis, keratitis including dendritic lesions, and uveitis. He was diagnosed with a cranial nerve VI palsy of the right eye secondary to herpes zoster infection. Since he already completed a course of antiviral therapy, it was decided to forego any further treatment, especially given evidence of disease regression with the healing of the dermatomal rash. Oral steroids were not prescribed. Close observation and follow-up were recommended. Return precautions, including worsening double vision, decreasing vision, eye pain, light sensitivity, and eye redness, were reviewed with the patient. At his follow-up, he reported the double vision resolved spontaneously approximately 3 to 4 weeks after the onset of the symptoms. This case was considered as suspected vaccination failure since the details regarding vaccination scheduled and TTO were unknown. This article is not available for regulatory reporting purpose due to copyright restriction. Upon internal review the case was updated on: 26-Aug-2024. Suspect product coding was updated. Summary of Changes: Product tab updated.; Sender's Comments: Vaccination failure is a listed event which is considered related to GSK Zoster vaccine. Ophthalmic herpes zoster and VIth nerve paralysis are unlisted events which are considered unrelated to GSK Zoster vaccine.
More
|
|||||||
| 2872176 | CA | 11/12/2025 |
FLU3 |
SANOFI PASTEUR |
U8832CA |
Expired product administered, No adverse event
Expired product administered, No adverse event
|
expiration date for a FLUBLOK vaccine given to a patient back in September, with no reported adverse...
expiration date for a FLUBLOK vaccine given to a patient back in September, with no reported adverse event; Initial information received on 03-Nov-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a patient with unknown age and gender who was given Influenza Trivalent Recombinant Vaccine [Flublok] and expiration date was back in september, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date in Sep-2025, the patient received an unknown dose of suspect Influenza Trivalent Recombinant Vaccine, Solution for injection (lot U8832CA, expiry date and strength not reported) via unknown route in unknown administration site for Immunisation and expiration date for a flublok vaccine given to a patient back in september, with no reported adverse event (expired product administered) (latency same day). Reportedly, due to caller having an unknown issue with expiration documentation of a dose of Flublok thus having the pharmacist seeking the correct information. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
More
|
||||||||
| 2872194 | 78 | F | OR | 11/12/2025 |
FLU3 |
SANOFI PASTEUR |
UT8804CA |
Erythema, Swelling
Erythema, Swelling
|
patient reported that she had a raised patch of redness a day after received her flu shot. it has go...
patient reported that she had a raised patch of redness a day after received her flu shot. it has gone away after a day with hot shower and some topical cream she used (not stated names of topical)
More
|
||||||
| 2872195 | 68 | M | HI | 11/12/2025 |
COVID19 |
MODERNA |
3052155 |
Conjunctival haemorrhage
Conjunctival haemorrhage
|
3 days after vaccination a subconjunctival hemorrhage developed in the nose side of the left eye. N...
3 days after vaccination a subconjunctival hemorrhage developed in the nose side of the left eye. No pain or other symptoms were noted. The area of blood in the white of the eye grew for 2 days covering the quadrant from 6 to 10 o'clock on a dial. On day 6 after appearance, the blood substantially cleared. The most recent prior subconjunctival hemorrhage occurred in 2014 in the right eye 1 day after cold symptoms appeared.
More
|
||||||
| 2872196 | 47 | F | OR | 11/12/2025 |
COVID19 FLU3 |
PFIZER\BIONTECH SANOFI PASTEUR |
|
Dizziness, Fatigue, Laboratory test, Migraine, Vertigo; Dizziness, Fatigue, Labo...
Dizziness, Fatigue, Laboratory test, Migraine, Vertigo; Dizziness, Fatigue, Laboratory test, Migraine, Vertigo
More
|
Extreme fatigue, Extreme dizziness/vertigo, migraines
Extreme fatigue, Extreme dizziness/vertigo, migraines
|
โ | |||||
| 2872197 | 6 | F | MI | 11/12/2025 |
FLU3 |
GLAXOSMITHKLINE BIOLOGICALS |
|
Injection site erythema, Injection site induration, Injection site warmth
Injection site erythema, Injection site induration, Injection site warmth
|
Injection site and 2? around became red, hot and hard. Ice and Zyrtec given. Urgent care visit 4 day...
Injection site and 2? around became red, hot and hard. Ice and Zyrtec given. Urgent care visit 4 days post injection since area is still red and hot, advised to monitor, continue Zyrtec and start epsom salt soaks
More
|
||||||
| 2872210 | M | 11/12/2025 |
FLUN3 |
MEDIMMUNE VACCINES, INC. |
|
Epistaxis
Epistaxis
|
THE REPORTER MENTIONED THAT SHE OBSERVED A CHILD BOY PATIENT TO HAVE A NOSEBLEED AFTER HAVING RECEIV...
THE REPORTER MENTIONED THAT SHE OBSERVED A CHILD BOY PATIENT TO HAVE A NOSEBLEED AFTER HAVING RECEIVED FLUMIST. SHE ASKED IF THEY COULD RECEIVE DEMONSTRATION VIDEOS ON HOW TO ADMINISTER FLUMIST TO HAVE A RESOURCE.; A spontaneous report has been received from a other health professional. The report concerns a male patient (age not provided). No medical history was reported. No concomitant products were reported. The patient received Flumist, via nasal use for vaccine/influenza prevention on an unknown date. The patient received 1 dose(s). No malfunction has been reported for the Accuspray Single Dose device. On an unknown date, the patient experienced the reporter mentioned that she observed a child boy patient to have a nosebleed after having received flumist. she asked if they could receive demonstration videos on how to administer flumist to have a resource. (preferred term: Epistaxis). The outcome of the event(s) of the reporter mentioned that she observed a child boy patient to have a nosebleed after having received flumist. she asked if they could receive demonstration videos on how to administer flumist to have a resource. was unknown. The event was considered non-serious. Device Information: Combination Product Report: Yes Product As Reported: Flumist Brand Name: FLUMIST Product Role:Suspect Device Problem code:Adverse Event Without Identified Device or Use Problem Manufacturer Name:ASTRAZENECA Labeled for single use:No Non-significant correction on 15-Oct-2025: Primary reporter information updated. Narrative amended. Insignificant correction 14-Oct-2025: Null flavor added to primary reporter. Case corrected as result of MCQC. Non-significant correction on 12-Nov-2025: Null flavor for telephone and fax removed, narrative amended.
More
|
||||||||
| 2872215 | 79 | F | GA | 11/12/2025 |
FLU3 |
SANOFI PASTEUR |
|
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
patient received 2 doses of fluzone hd in the same season with no reported adverse event; Initial in...
patient received 2 doses of fluzone hd in the same season with no reported adverse event; Initial information received on 07-Nov-2025 regarding an unsolicited valid non-serious case received from a patient. This case involves a 79 years old female patient who received 2 doses of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HD] in the same season with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 28-Oct-2025 the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE Suspension for injection in pre-filled syringe (dose, batch and expiry date unknown) via unknown route in unknown administration site for Influenza (Influenza immunization). On 07-Nov-2025, the patient again received INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE dose 0.5 ml 1x(once) lot UT8781DA expiry date-30-Jun-2026 via intramuscular route in the left upper arm for Influenza (Influenza immunization) in the same season with no reported adverse event (extra dose administered) (latency same day). Action taken-not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
More
|
||||||
| 2872216 | 47 | F | FL | 11/12/2025 |
FLUX |
UNKNOWN MANUFACTURER |
|
Influenza like illness, Malaise, Oropharyngeal pain, Pyrexia, Sinus congestion
Influenza like illness, Malaise, Oropharyngeal pain, Pyrexia, Sinus congestion
|
Had flu vaccine on Monday 27th October and then on the Thursday became sick with flu like symptoms (...
Had flu vaccine on Monday 27th October and then on the Thursday became sick with flu like symptoms (sore throat, sinus congestion, fever) and am still sick as on Monday 3rd November
More
|
||||||
| 2872217 | NM | 11/12/2025 |
COVID19 |
MODERNA |
3052741 |
Product container issue
Product container issue
|
Describe Event, Problem, or Product Use Error: Three doses of Moderna spikevax 2025-26 formula were ...
Describe Event, Problem, or Product Use Error: Three doses of Moderna spikevax 2025-26 formula were empty upon receipt at providers' office
More
|
||||||||
| 2872218 | 56 | M | IL | 11/12/2025 |
COVID19 COVID19 FLUX FLUX |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
|
Blood test, Cardiac monitoring, Computerised tomogram, Dysstasia, Gait inability...
Blood test, Cardiac monitoring, Computerised tomogram, Dysstasia, Gait inability; Guillain-Barre syndrome, Magnetic resonance imaging spinal, Musculoskeletal disorder, Nerve conduction studies abnormal; Blood test, Cardiac monitoring, Computerised tomogram, Dysstasia, Gait inability; Guillain-Barre syndrome, Magnetic resonance imaging spinal, Musculoskeletal disorder, Nerve conduction studies abnormal
More
|
On 10/18/2024, my husband had the covid and flu shots administered together at a pharmacy (city, sta...
On 10/18/2024, my husband had the covid and flu shots administered together at a pharmacy (city, state withheld). On 10/21, he developed Gillain-Barre' and was unable to walk, use his hands or stand up straight without hold onto something. After a series of tests, it was determined he had Gillain-Barre'.
More
|
โ | |||||
| 2872219 | 64 | F | NY | 11/12/2025 |
FLUX |
UNKNOWN MANUFACTURER |
|
Bronchitis, Malaise, Sinusitis, Urticaria
Bronchitis, Malaise, Sinusitis, Urticaria
|
Patient received a flu shot and dosed her Simlandi 40mg pen 3 days later. She then fell ill with a s...
Patient received a flu shot and dosed her Simlandi 40mg pen 3 days later. She then fell ill with a sinus infection and bronchitis, and then started to develop hives in her thighs where she does the Simlandi injections. She normally takes daily allegra, but stopped it while sick as it exacerbated her illness, and that is when the hives appeared. Confirmed she rotates injection sites when she does her injections, and has withheld dose while this is occurring.
More
|
||||||
| 2872220 | F | ME | 11/12/2025 |
COVID19 |
MODERNA |
|
Pruritus, Urticaria
Pruritus, Urticaria
|
Pruritis with long-term cetirizine use. I started using OTC cetirizine in 2021 when I moved to a new...
Pruritis with long-term cetirizine use. I started using OTC cetirizine in 2021 when I moved to a new area and was experiencing fall allergies that I'd never had before. I had used it for childhood allergies and used it prn as an adult. I continue to use it about half of the time because it makes me drowsy, so if I was working a long shift the next day I would skip it the night before. I started to noticed that if I hadn't taken it for 2-3 days in a row, I would get hives very easily and be itchy all over. That would go away shortly after taking another one. I believe it was 2022 when I started to notice this, maybe early 2023. I still take 5-10mg of cetirizine almost every night, because I will start to get hives / itchiness 24-48 hours after taking it. I've tried cutting down to 5mg recently but the effects seem to wear off a little earlier. I told my doctor about this in June but I don't think he reported it, he suggested maybe switching to another antihistamine which I will try. Also, there were case studies a few years ago about patients who received Moderna having pruritis that goes away with cetirizine. I did not have a moderna vaccine until 2022, so the timing would be right. I am not sure if these two things are connected, but I think it's interesting that this is a drug that has been around for a long time and only now people are reporting this side effect. I'm a pharmacist and not anti-vax. I even got moderna again this year, to be clear. But I have a feeling this could be connected. I have used brand Zyrtec, store off-brand and store off-brand, I am not certain which I was using when I started to notice the issue.
More
|
|||||||
| 2872273 | 28 | F | NC | 11/12/2025 |
FLU3 FLU3 |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
4F2AJ 4F2AJ |
Dizziness, Headache, Injection site rash, Musculoskeletal pain, Neck pain; Pain,...
Dizziness, Headache, Injection site rash, Musculoskeletal pain, Neck pain; Pain, Pain in extremity
More
|
Dizziness, feeling faint, left arm pain that is radiating to left scapula and into left side of neck...
Dizziness, feeling faint, left arm pain that is radiating to left scapula and into left side of neck and headache. Patient reports having similar symptom the previous year but with localized rash at injection site.
More
|